These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17099698)

  • 41. A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase.
    Nishida T; Tanaka H; Yasuda H
    Eur J Biochem; 2000 Nov; 267(21):6423-7. PubMed ID: 11029585
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins.
    Song J; Durrin LK; Wilkinson TA; Krontiris TG; Chen Y
    Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14373-8. PubMed ID: 15388847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection and characterization of SUMO protease activity using a sensitive enzyme-based reporter assay.
    Leach CA; Tian X; Mattern MR; Nicholson B
    Methods Mol Biol; 2009; 497():269-81. PubMed ID: 19107424
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isoform-specific monobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library design.
    Gilbreth RN; Truong K; Madu I; Koide A; Wojcik JB; Li NS; Piccirilli JA; Chen Y; Koide S
    Proc Natl Acad Sci U S A; 2011 May; 108(19):7751-6. PubMed ID: 21518904
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Desumoylation of homeodomain-interacting protein kinase 2 (HIPK2) through the cytoplasmic-nuclear shuttling of the SUMO-specific protease SENP1.
    Kim YH; Sung KS; Lee SJ; Kim YO; Choi CY; Kim Y
    FEBS Lett; 2005 Nov; 579(27):6272-8. PubMed ID: 16253240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Small-molecule inhibitors and probes for ubiquitin- and ubiquitin-like-specific proteases.
    Borodovsky A; Ovaa H; Meester WJ; Venanzi ES; Bogyo MS; Hekking BG; Ploegh HL; Kessler BM; Overkleeft HS
    Chembiochem; 2005 Feb; 6(2):287-91. PubMed ID: 15651044
    [No Abstract]   [Full Text] [Related]  

  • 47. Small ubiquitin-like modifier 1 [corrected] mediates the resistance of prosthesis-loosening fibroblast-like synoviocytes against Fas-induced apoptosis.
    Meinecke I; Pap G; Mendoza H; Drange S; Ender S; Strietholt S; Gay RE; Seyfert C; Ink B; Gay S; Pap T; Peters MA
    Arthritis Rheum; 2009 Jul; 60(7):2065-70. PubMed ID: 19565496
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SUMO-specific protease 1 is critical for early lymphoid development through regulation of STAT5 activation.
    Van Nguyen T; Angkasekwinai P; Dou H; Lin FM; Lu LS; Cheng J; Chin YE; Dong C; Yeh ET
    Mol Cell; 2012 Jan; 45(2):210-21. PubMed ID: 22284677
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SUMO wrestling with specificity.
    VanDemark AP; Hill CP
    Structure; 2002 Mar; 10(3):281-2. PubMed ID: 12005425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent research and development of inhibitors targeting sentrin-specific protease 1 for the treatment of cancers.
    Wei J; Wang H; Zheng Q; Zhang J; Chen Z; Wang J; Ouyang L; Wang Y
    Eur J Med Chem; 2022 Nov; 241():114650. PubMed ID: 35939992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Domain alternation and active site remodeling are conserved structural features of ubiquitin E1.
    Lv Z; Yuan L; Atkison JH; Aldana-Masangkay G; Chen Y; Olsen SK
    J Biol Chem; 2017 Jul; 292(29):12089-12099. PubMed ID: 28572513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
    Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SUMO-specific proteases: a twist in the tail.
    Hay RT
    Trends Cell Biol; 2007 Aug; 17(8):370-6. PubMed ID: 17768054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SENP1-mediated GATA1 deSUMOylation is critical for definitive erythropoiesis.
    Yu L; Ji W; Zhang H; Renda MJ; He Y; Lin S; Cheng EC; Chen H; Krause DS; Min W
    J Exp Med; 2010 Jun; 207(6):1183-95. PubMed ID: 20457756
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of a novel mammalian SUMO-1/Smt3-specific isopeptidase, a homologue of rat axam, which is an axin-binding protein promoting beta-catenin degradation.
    Nishida T; Kaneko F; Kitagawa M; Yasuda H
    J Biol Chem; 2001 Oct; 276(42):39060-6. PubMed ID: 11489887
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML.
    Fasci D; Anania VG; Lill JR; Salvesen GS
    Sci Signal; 2015 Jun; 8(380):ra56. PubMed ID: 26060329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of inducible nitric oxide synthase expression by sumoylation.
    Akar CA; Feinstein DL
    J Neuroinflammation; 2009 Mar; 6():12. PubMed ID: 19323834
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SENP1 participates in the dynamic regulation of Elk-1 SUMOylation.
    Witty J; Aguilar-Martinez E; Sharrocks AD
    Biochem J; 2010 May; 428(2):247-54. PubMed ID: 20337593
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ZNF451 is a novel PML body- and SUMO-associated transcriptional coregulator.
    Karvonen U; Jääskeläinen T; Rytinki M; Kaikkonen S; Palvimo JJ
    J Mol Biol; 2008 Oct; 382(3):585-600. PubMed ID: 18656483
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Streptonigrin Inhibits SENP1 and Reduces the Protein Level of Hypoxia-Inducible Factor 1α (HIF1α) in Cells.
    Ambaye N; Chen CH; Khanna S; Li YJ; Chen Y
    Biochemistry; 2018 Mar; 57(11):1807-1813. PubMed ID: 29481054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.